Recombinant CD38 (Daratumumab Biosimilar) antibody
The Human Monoclonal anti-CD38 (Daratumumab Biosimilar) antibody is suitable to detect CD38 (Daratumumab Biosimilar) in samples from Human. It has been validated for FACS, ELISA, BLI, Func and SPR.
Catalog No. ABIN7675652
$346.15
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 12 Business Days
Quick Overview for Recombinant CD38 (Daratumumab Biosimilar) antibody (ABIN7675652)
Target
CD38 (Daratumumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This CD38 (Daratumumab Biosimilar) antibody is un-conjugated
Application
Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-CD38 Reference Antibody (daratumumab)
-
Characteristics
- Anti-CD38 Reference Antibody (daratumumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.34 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
anti-CD38 (Daratumumab Biosimilar) antibody
Research Grade Reactivity: Human FACS, ELISA Host: Human Monoclonal unconjugated Recombinant Antibody
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Conditions: Multiple Myeloma
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- CD38 (Daratumumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Synonyms: cADPr hydrolase 1, T10
-
Molecular Weight
- 145.34 kDa
-
UniProt
- P28907
Target
-
You are here:
